Reported about 9 hours ago
CVS CEO David Joyner's cautious and prudent management approach has led to a nearly 15% stock increase following the company's earnings report for 2024, which surpassed expectations. Despite not providing full revenue guidance for 2025, Joyner estimated adjusted earnings per share and defended the company's pharmacy benefit manager amidst ongoing scrutiny in the healthcare sector. He emphasized the need for conservative projections to rebuild investor confidence after previous challenges faced by the company.
Source: YAHOO